Anticoagulants and Bleeding Disorders: Clinical Trials

5 trials for Anticoagulants and Bleeding Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 enrolling by invitation, 1 recruiting. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1

Follow Anticoagulants and Bleeding Disorders: new trials by email Literature Review of Anticoagulants and Bleeding Disorders trials Research Report on Anticoagulants and Bleeding Disorders

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients
catheter flushing techniques - Anticoagulants and Bleeding Disorders
Not applicableRecruitingCentre Hospitalier Régional d'Orléans302025-09-222025-11-25
Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation
Storytelling Intervention - Atrial Fibrillation, Atrial Flutter
Not applicableEnrolling by invitationUniversity of Massachusetts, Worcester802024-06-242026-04-13
Bleeding Oral Anticoagulant Analyzer (BOA)
Quantra analyzer - Anticoagulants and Bleeding Disorders
Not applicableCompletedUniversity Hospital, Clermont-Ferrand802021-12-162024-02-07
Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet) - Atrial Fibrillation, Anticoagulants and Bleeding Disorders
Not applicableActive not recruitingR&D Cardiologie6092021-01-012024-06-21
Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
Edoxaban, Warfarin - Atrial Fibrillation, Anticoagulants and Bleeding Disorders
Not applicableCompletedSamsung Medical Center602017-12-012020-08-03

Narrower conditions

Hemostatic Disorders (5)  ·  Atrial Fibrillation (3)  ·  Hemorrhage (2)  ·  Stroke (2)  ·  Atrial Flutter (1)  ·  Emergencies (1)  ·  Medication Adherence (1)  ·  Narration (1)

Broader conditions

Cardiovascular Diseases (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Vascular Diseases (5)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Arrhythmias, Cardiac (3)  ·  Heart Diseases (3)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Behavior (1)  ·  Communication (1)

Interventions

Warfarin (1)  ·  edoxaban (1)

Sponsors

Centre Hospitalier Régional d'Orléans (1)  ·  R&D Cardiologie (1)  ·  Samsung Medical Center (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Massachusetts, Worcester (1)

Countries

France (2)  ·  Netherlands (1)  ·  South Korea (1)  ·  United States (1)

Top investigators

Alok Kapoor, MD (1)  ·  Dong Seop Jeong, PhD (1)  ·  Dorian Teissandier (1)  ·  Lucas VA Boersma, Prof. Dr. (1)

Results publications

PMID 35537503

NIH funding

R21MD017646 (1)